Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus

Gynecological Endocrinology

Volumn 28, Issue 1, 2012, Pages 76-79

  Yilmaz, Özgür ^a   Küçük, Mert ^b   Kebapçilar, Levent ^c   Altindag, Tamer ^d   Ÿksel, Arif ^e   Yuvanç, Hüseyin Oguz ^f   Dal, Tuba ^f   Savran, Yusuf ^g  

^a Akhisar State Hospital   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

^d Obstetrician and Gynecologist   (Turkey)

^e UNIVERSITY OF HEALTH SCIENCES   (Turkey)

^f Bismil State Hospital   (Turkey)

^g Department of Internal Medicine   (Turkey)

Author keywords

Gestational diabetes mellitus; Macrophage migration inhibitory factor; Pregnancy

Indexed keywords

INSULIN; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; VENOUS BLOOD;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PREGNANT WOMEN; YOUNG ADULT;

EID: 83655165038     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.588757     Document Type: Article

References (43)

1. Gabbe SG. Definition, detection, and management of gestational diabetes. Obstet Gynecol 1986;67:121-125. (Pubitemid 16174313)
2. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21 (Suppl 2):B161-B167. (Pubitemid 28357050)
3. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2000;23 (Suppl 1):S77-S79.
4. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS; Kaiser Permanente of Colorado GDM Screening Program. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 2005;28:579-584. (Pubitemid 40315316)
5. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol 2004;103:526-533. (Pubitemid 40459069)
6. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-2486.
7. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 2004;21:103-113. (Pubitemid 38221808)
8. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007;30:878-883. (Pubitemid 46556581)
9. ACOG. Guidelines for perinatal care. 4th ed. Washington, DC: American Council of Obstetricians and Gynecologists; 1997.
10. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000;49:2208-2211.
11. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003;133:1674S-1683S. (Pubitemid 36548675)
12. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-82.
13. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966;56:72-77.
14. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-759. (Pubitemid 23339882)
15. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179:1895-1902. (Pubitemid 24155670)
16. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997;158:5514-5517. (Pubitemid 127681261)
17. Shimizu T, Nishihira J, Mizue Y, Nakamura H, Abe R, Watanabe H, Ohkawara A, Shimizu H. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 2001;116:989-990. (Pubitemid 32554390)
18. Nishihira J, Ogata A. Macrophage migration inhibitory factor as atarget molecule in multiple sclerosis. Curr Opin Investig Drugs 2001;2: 778-782. (Pubitemid 32936670)
19. Gando S, Nishihira J, Kobayashi S, Morimoto Y, Nanzaki S, Kemmotsu O. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med 2001;27:1187-1193. (Pubitemid 32710206)
20. Taguchi C, Sugita S, Tagawa Y, Nishihira J, Mochizuki M. Macrophage migration inhibitory factor in ocular fluids of patients with uveitis. Br J Ophthalmol 2001;85:1367-1371. (Pubitemid 33016122)
21. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, Bucala R. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996;183:277-282. (Pubitemid 26028767)
22. Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, et al. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol 2008;215:665-675. (Pubitemid 351632688)
23. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
24. Hanifi-Moghaddam P, Schloot NC, Kappler S, Seissler J, Kolb H. An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes 2003;52:1137-1142. (Pubitemid 36523347)
25. Herder C, Kolb H, Koenig W, Haastert B, Méler-Scholze S, Rathmann W, Holle R, et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 2006;29:368-371. (Pubitemid 44106520)
26. Herder C, Klopp N, Baumert J, Méler M, Khuseyinova N, Meisinger C, Martin S, et al. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia 2008;51:276-284.
27. Amoli MM, Donn RP, Thomson W, Hajeer AH, Garcia-Porrua C, Lueiro M, Ollier WE, Gonzalez-Gay MA. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002;29:1671-1673. (Pubitemid 34831240)
28. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002;3:170-176. (Pubitemid 38961128)
29. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K, Kikuchi K, Mukai M. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 2000;5:397-403.
30. Petrovsky N, Socha L, Silva D, Grossman AB, Metz C, Bucala R. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counterregulator. Immunol Cell Biol 2003;81:137-143. (Pubitemid 36403424)
31. Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N, Thorens B, et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997;94:4782-4787. (Pubitemid 27194321)
32. Vozarova B, Stefan N, Hanson R, Lindsay RS, Bogardus C, Tataranni PA, Metz C, Bucala R. Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia 2002;45:1739-1741. (Pubitemid 35478148)
33. Atsumi T, Cho YR, Leng L, McDonald C, Yu T, Danton C, Hong EG, et al. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 2007;179:5399-5406.
34. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994;91:4854-4858. (Pubitemid 24177748)
35. Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 2004;89:5043-5047. (Pubitemid 39391446)
36. Stojanovic I, Lazaroski S, Nicoletti F, Stosic-Grujicic S. Lack of macrophage migration inhibitory factor (MIF) confers resistance to immunoinflammatory diabetes in mice. Diabetologia 2007;50:S187.
37. Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy. Br J Ophthalmol 2000;84:636-639. (Pubitemid 30339318)
38. Enquobahrie DA, Williams MA, Qiu C, Meller M, Sorensen TK. Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 2009;200:206.e1-206.13.
39. Hristoskova S, Holzgreve W, Zhong XY, Hahn S. Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia. Arch Gynecol Obstet 2006;274:25-28.
40. Khandelwal M, Homko C, Reece EA. Gestational diabetes mellitus: controversies and current opinions. Curr Opin Obstet Gynecol 1999;11:157-165. (Pubitemid 29165020)
41. Yabunaka N, Nishihira J, Mizue Y, Tsuji M, Kumagai M, Ohtsuka Y, Imamura M, Asaka M. Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care 2000;23:256-258. (Pubitemid 30071036)
42. Taricco E, Radaelli T, Nobile de Santis MS, Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta 2003;24:343-347. (Pubitemid 37184752)
43. Kucuk M, Doymaz F. Placental weight and placental weight-to-birth weight ratio are increased in diet- and exercise-treated gestational diabetes mellitus subjects but not in subjects with one abnormal value on 100-g oral glucose tolerance test. J Diabetes Complicat 2009;23:25-31.